Mehdi Seema, Manohar Kishor, Shariff Atiqulla, Kinattingal Nabeel, Wani Shahid Ud Din, Alshehri Sultan, Imam Mohammad T, Shakeel Faiyaz, Krishna Kamsagara L
Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher education and Research, Mysuru 570015, India.
Department of Psychiatry, JSS Medical College and Hospital, JSS Academy of Higher Education & Research, Mysuru 570015, India.
J Pers Med. 2023 Jan 27;13(2):224. doi: 10.3390/jpm13020224.
Depression is a common mood disorder characterized by persistent sadness and loss of interest. Research suggests an association between the inclusion of omega-3 fatty acids in the diet and a reduced risk for depression. The present study evaluated the effectiveness of omega-3 fatty acid supplements in alleviating depressive symptoms in patients with mild to moderate depression. A total of 165 patients suffering from mild to moderated depression were randomized to receive omega-3 fatty acid supplementation, an antidepressant (single agent), or a combination of an antidepressant and omega-3 fatty acid supplementation. The clinical features of depression were assessed using the Hamilton Depression Rating Scale (HDRS) during the follow-up period. A statistically significant improvement in depressive symptoms was observed from baseline to first, second and third follow-ups within each treatment arm as measured by HRDS scores ( = 0.00001). Further, the HDRS scores at the third follow-up were significantly lower in patients on combination therapy of omega-3 fatty acid supplement and antidepressants (arm-3) than the patients on the omega-3 fatty acid supplement alone (arm-1) [Q = 5.89; = 0.0001] or the patients taking an antidepressant alone (arm 2) [Q = 4.36; = 0.0068]. The combination of an omega-3 fatty acid supplement and an antidepressant elicited significantly higher improvement in depressive symptoms than the supplement or the antidepressant alone.
抑郁症是一种常见的情绪障碍,其特征为持续的悲伤和兴趣丧失。研究表明,饮食中摄入omega-3脂肪酸与降低抑郁症风险之间存在关联。本研究评估了omega-3脂肪酸补充剂对缓解轻至中度抑郁症患者抑郁症状的有效性。总共165名患有轻至中度抑郁症的患者被随机分配接受omega-3脂肪酸补充剂、一种抗抑郁药(单一药物)或抗抑郁药与omega-3脂肪酸补充剂的组合。在随访期间,使用汉密尔顿抑郁量表(HDRS)评估抑郁症的临床特征。根据HRDS评分,在每个治疗组中,从基线到第一次、第二次和第三次随访时,抑郁症状均有统计学上的显著改善(P = 0.00001)。此外,在第三次随访时,接受omega-3脂肪酸补充剂和抗抑郁药联合治疗的患者(第3组)的HDRS评分显著低于仅接受omega-3脂肪酸补充剂的患者(第1组)[Q = 5.89;P = 0.0001]或仅服用抗抑郁药的患者(第2组)[Q = 4.36;P = 0.0068]。与单独使用补充剂或抗抑郁药相比,omega-3脂肪酸补充剂和抗抑郁药的组合在改善抑郁症状方面有显著更高的效果。